The lateralization accuracy of inferior petrosal sinus sampling in Cushing's disease: experiences of a tertiary center.
Cushing’s disease
bilateral inferior petrosal sinus sampling
lateralization
magnetic resonance imaging
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
21
03
2021
accepted:
25
08
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
29
11
2022
Statut:
ppublish
Résumé
The purpose of this study is to determine the accuracy of bilateral inferior petrosal sinus sampling (IPSS) in lateralization and to investigate variables associated with accurate IPSS lateralization prediction. Initially, data from 55 patients who underwent IPSS in our institution were reviewed retrospectively. IPSS lateralization and pituitary magnetic resonance imaging (MRI) results of these patients were compared with postoperative follow-up and immunohistochemical data to calculate the positive predictive values (PPVs) for IPSS and MRI. Variables likely to be associated with the accurate prediction of IPSS lateralization were analyzed. Twenty-seven patients (85.2% female, mean age of 38.5 ± 13.1 years) were enrolled in the study. With IPSS, interpetrosal ratios were found to be ≥ 1.4 in 26 (96.2%) cases, and this ratio correctly predicted adenoma localization for 18 patients (PPV: 69.2%). For 16 (59.2%) patients, right lateralization was detected, while left lateralization was detected for 10 (37%) patients. Right-sided IPSS lateralization was associated with enhanced accuracy (p = 0.026). No masses were detected in the MRI images of 10 (37%) patients, while microadenoma of ≤ 6 mm was detected for 17 (63%) patients. MRI results (when positive) correctly identified adenoma localization for 14 of the patients with lateralization accuracy higher than that of IPSS (PPV: 82.3% vs. 69.2%). IPSS is a valuable procedure in detecting tumor lateralization, especially in patients with Cushing's disease who have negative pituitary MRI results. However, since lateralization has a limited reliability, the pituitary gland should be comprehensively evaluated by taking into account the MRI findings (if positive) as well as data on the side of IPSS lateralization.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this study is to determine the accuracy of bilateral inferior petrosal sinus sampling (IPSS) in lateralization and to investigate variables associated with accurate IPSS lateralization prediction.
METHODS
METHODS
Initially, data from 55 patients who underwent IPSS in our institution were reviewed retrospectively. IPSS lateralization and pituitary magnetic resonance imaging (MRI) results of these patients were compared with postoperative follow-up and immunohistochemical data to calculate the positive predictive values (PPVs) for IPSS and MRI. Variables likely to be associated with the accurate prediction of IPSS lateralization were analyzed.
RESULTS
RESULTS
Twenty-seven patients (85.2% female, mean age of 38.5 ± 13.1 years) were enrolled in the study. With IPSS, interpetrosal ratios were found to be ≥ 1.4 in 26 (96.2%) cases, and this ratio correctly predicted adenoma localization for 18 patients (PPV: 69.2%). For 16 (59.2%) patients, right lateralization was detected, while left lateralization was detected for 10 (37%) patients. Right-sided IPSS lateralization was associated with enhanced accuracy (p = 0.026). No masses were detected in the MRI images of 10 (37%) patients, while microadenoma of ≤ 6 mm was detected for 17 (63%) patients. MRI results (when positive) correctly identified adenoma localization for 14 of the patients with lateralization accuracy higher than that of IPSS (PPV: 82.3% vs. 69.2%).
DISCUSSION
CONCLUSIONS
IPSS is a valuable procedure in detecting tumor lateralization, especially in patients with Cushing's disease who have negative pituitary MRI results. However, since lateralization has a limited reliability, the pituitary gland should be comprehensively evaluated by taking into account the MRI findings (if positive) as well as data on the side of IPSS lateralization.
Identifiants
pubmed: 36422478
doi: 10.55730/1300-0144.5500
pmc: PMC10395702
doi:
Substances chimiques
Adrenocorticotropic Hormone
9002-60-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1600-1608Références
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
N Engl J Med. 2020 Mar 5;382(10):937-950
pubmed: 32130815
Exp Clin Endocrinol Diabetes. 2021 Feb;129(2):126-130
pubmed: 31426111
Diagn Interv Radiol. 2012 Jan-Feb;18(1):132-8
pubmed: 21348009
J Clin Endocrinol Metab. 1998 May;83(5):1485-8
pubmed: 9589643
J Neurointerv Surg. 2017 Feb;9(2):196-199
pubmed: 26880723
J Clin Endocrinol Metab. 1999 Feb;84(2):533-40
pubmed: 10022412
Clin Endocrinol (Oxf). 2018 Feb;88(2):251-257
pubmed: 29080355
J Clin Endocrinol Metab. 2013 Jun;98(6):2285-93
pubmed: 23553862
Eur J Endocrinol. 2001 May;144(5):499-507
pubmed: 11331216
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31
pubmed: 26222757
Eur J Endocrinol. 2007 Sep;157(3):271-7
pubmed: 17766708
Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875
pubmed: 34687601
AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1183-90
pubmed: 8237701
J Clin Endocrinol Metab. 2003 Jan;88(1):196-203
pubmed: 12519852
N Engl J Med. 1991 Sep 26;325(13):897-905
pubmed: 1652686
J Clin Endocrinol Metab. 1996 Feb;81(2):475-81
pubmed: 8636253